These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19733597)

  • 21. Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice.
    Vacher CM; Gassmann M; Desrayaud S; Challet E; Bradaia A; Hoyer D; Waldmeier P; Kaupmann K; Pévet P; Bettler B
    J Neurochem; 2006 May; 97(4):979-91. PubMed ID: 16606363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington's disease.
    Abada YS; Schreiber R; Ellenbroek B
    Behav Brain Res; 2013 Feb; 238():243-51. PubMed ID: 23123142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease.
    Cabanas M; Bassil F; Mons N; Garret M; Cho YH
    PLoS One; 2017; 12(9):e0184580. PubMed ID: 28934250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function.
    Sano H; Yasoshima Y; Matsushita N; Kaneko T; Kohno K; Pastan I; Kobayashi K
    J Neurosci; 2003 Oct; 23(27):9078-88. PubMed ID: 14534241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethological resolution of behavioral topography and D2-like vs. D1-like agonist responses in congenic D4 dopamine receptor "knockouts": identification of D4:D1-like interactions.
    O'Sullivan GJ; Kinsella A; Grandy DK; Tighe O; Croke DT; Waddington JL
    Synapse; 2006 Feb; 59(2):107-18. PubMed ID: 16320306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regionally selective changes in neurotransmitter receptors in the brain of the 5-HT1B knockout mouse.
    Ase AR; Reader TA; Hen R; Descarries L
    J Chem Neuroanat; 2008 Jul; 35(4):356-63. PubMed ID: 18406571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains.
    Smith Y; Villalba R
    Mov Disord; 2008; 23 Suppl 3():S534-47. PubMed ID: 18781680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function.
    Pallier PN; Drew CJ; Morton AJ
    Brain Res Bull; 2009 Mar; 78(6):347-55. PubMed ID: 19010400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural characterisation of young adult transgenic mice overexpressing galanin under the PDGF-B promoter.
    Kuteeva E; Hökfelt T; Ogren SO
    Regul Pept; 2005 Feb; 125(1-3):67-78. PubMed ID: 15582716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia.
    Dang MT; Yokoi F; McNaught KS; Jengelley TA; Jackson T; Li J; Li Y
    Exp Neurol; 2005 Dec; 196(2):452-63. PubMed ID: 16242683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular prion protein regulates the motor behaviour performance and anxiety-induced responses in genetically modified mice.
    Lobão-Soares B; Walz R; Carlotti CG; Sakamoto AC; Calvo F; Terzian AL; da Silva JA; Wichert-Ana L; Coimbra NC; Bianchin MM
    Behav Brain Res; 2007 Oct; 183(1):87-94. PubMed ID: 17618696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive loss of striatal neurons causes motor dysfunction in MND2 mutant mice and is not prevented by Bcl-2.
    Rathke-Hartlieb S; Schlomann U; Heimann P; Meisler MH; Jockusch H; Bartsch JW
    Exp Neurol; 2002 May; 175(1):87-97. PubMed ID: 12009762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males.
    Bode FJ; Stephan M; Suhling H; Pabst R; Straub RH; Raber KA; Bonin M; Nguyen HP; Riess O; Bauer A; Sjoberg C; Petersén A; von Hörsten S
    Hum Mol Genet; 2008 Sep; 17(17):2595-609. PubMed ID: 18502785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative, topographically-based evaluation of behavioural phenotype and specification of D(1)-like:D(2) interactions in a line of incipient congenic mice with D(2) dopamine receptor 'knockout'.
    Clifford JJ; Kinsella A; Tighe O; Rubinstein M; Grandy DK; Low MJ; Croke DT; Waddington JL
    Neuropsychopharmacology; 2001 Oct; 25(4):527-36. PubMed ID: 11557166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
    Ballion B; Frenois F; Zold CL; Chetrit J; Murer MG; Gonon F
    Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The roles of accumbal dopamine D1 and D2 receptors in maternal memory in rats.
    Parada M; King S; Li M; Fleming AS
    Behav Neurosci; 2008 Apr; 122(2):368-76. PubMed ID: 18410175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novelty-seeking behaviors and the escalation of alcohol drinking after abstinence in mice are controlled by metabotropic glutamate receptor 5 on neurons expressing dopamine d1 receptors.
    Parkitna JR; Sikora M; Gołda S; Gołembiowska K; Bystrowska B; Engblom D; Bilbao A; Przewlocki R
    Biol Psychiatry; 2013 Feb; 73(3):263-70. PubMed ID: 22902169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.
    Berenguer I; El Aouad N; Andujar S; Romero V; Suvire F; Freret T; Bermejo A; Ivorra MD; Enriz RD; Boulouard M; Cabedo N; Cortes D
    Bioorg Med Chem; 2009 Jul; 17(14):4968-80. PubMed ID: 19540762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor.
    Clifford JJ; Usiello A; Vallone D; Kinsella A; Borrelli E; Waddington JL
    Neuropharmacology; 2000 Jan; 39(3):382-90. PubMed ID: 10698004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential conservation of D1 mutant phenotype at the level of individual topographies of behaviour in mice lacking both D1 and D3 dopamine receptors.
    Wong JY; Clifford JJ; Massalas JS; Kinsella A; Waddington JL; Drago J
    Psychopharmacology (Berl); 2003 May; 167(2):167-73. PubMed ID: 12652349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.